Tianyi Li
Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Multi-omics insights into metastatic pheochromocytomas and paragangliomas: Mechanisms, signatures, and prediction models.
Journal: Hormones (Athens, Greece)
Published: December 08, 2025
Clinical relevance of HRD score in pheochromocytomas and paragangliomas: molecular cluster distribution and prognostic implications.
Journal: Endocrine-related cancer
Published: August 06, 2025
Types of pancreatic lesions and the mutational landscape of the VHL gene in patients with von Hippel-Lindau disease.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: June 29, 2025
PBK as a Potential Biomarker and Therapeutic Target for Metastatic Pheochromocytomas and Paragangliomas.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 27, 2025
An in-depth exploration of the catecholamine and dyslipidemia relationship in pheochromocytoma and paraganglioma patients: a large Chinese cohort study.
Journal: Endocrine
Published: March 04, 2025
A study on the efficacy and safety of anlotinib in patients with metastatic pheochromocytoma and paraganglioma.
Journal: Endocrine-related cancer
Published: December 04, 2024
Why do patients with pheochromocytomas/paragangliomas exhibit significantly inconsistent elevation of catecholamines and their metabolites? a large Chinese cohort study.
Journal: Endocrine
Published: September 19, 2024
Glucose Disorders in Patients With Pheochromocytoma/Paraganglioma: Profile and Influence Effects in a Large Cohort With 705 Patients.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: August 03, 2024
Alterations and Clinical Value of Peripheral Lymphocyte Subsets and Inflammatory Factors in Paragangliomas.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 24, 2024
Development and internal validation of a novel predictive model for SDHB mutations in pheochromocytomas and retroperitoneal paragangliomas.
Journal: Frontiers in endocrinology
Published: August 30, 2023
Case report: Antiplatelet therapy on metastatic paraganglioma-associated cutaneous vascular disease and literature review.
Journal: Frontiers in medicine
Published: October 12, 2022
Last Updated: 09/26/2026